Inventor · disambiguated record
Brian Betts
Also filed as: BETTS BRIAN · BETTS BRIAN C
4 granted patents·15 pending applications·1 citations·filing 2015–2024
59Inventor score
Top patents by PatentIndex Score
19 records- 0180US2024368089A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 0278US12060332B2Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Aug 13, 2024·0 cites·3 claims
- 0377US12492254B2CD83-binding chimeric antigen receptorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Dec 9, 2025·1 cites·15 claims
- 0471US2022281828A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 0569US2024197779A1Anti-cd83 chimeric antigen receptor expressing t regulatory cellsH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 0663US11203576B2Aurora kinase and Janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Dec 21, 2021·0 cites·11 claims
- 0759US2025241952A1Cd83 dual car t cellsH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 0857US2025052748A1Cd83 and allo- and autoimmune conditionsUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 0956US2020108098A1Anti-cd83 chimeric antigen receptor expressing t regulatory cellsH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 1056US2024269284A1Methods of using anti-cd83 chimeric antigen receptor expressing t cellsH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1155US2021069199A1Methods of treating transplant rejectionCTI BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1254US2024173411A1Methods for treating cd83-expressing cancerH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1352US2023321239A1Chimeric antigen receptor t cells for treating autoimmunityH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1451US2022289862A1Anti-cd83 chimeric antigen receptor expressing t regulatory cellsH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 1550US2023390391A1Bi-specific chimeric antigen receptor t cells targeting cd83 and interleukin 6 receptorUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 1648US2022289813A1Chimeric antigen receptors for treating myeloid malignanciesH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 1748US2018318306A1Methods of treating transplant rejectionCTI BIOPHARMA CORP·Filed 2016·Application pending·0 cites
- 1846US2023060230A1Hdac6-inhibited human regulatory t cellsH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1935US11406707B2STAT3 phosphorylation during graft-versus-host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Aug 9, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Brian Betts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →